博瑞医药:10月30日回购公司股份55880股

Core Viewpoint - 博瑞医药 announced its first share buyback on October 30, 2025, through the Shanghai Stock Exchange, repurchasing 55,880 shares, which represents 0.0132% of the company's total share capital [1] Summary by Category - Company Actions - 博瑞医药 executed a share buyback of 55,880 shares [1] - The buyback was conducted via centralized bidding on the Shanghai Stock Exchange [1] - Financial Impact - The repurchased shares account for 0.0132% of the total share capital of the company [1]

BrightGene Bio-medical Technology-博瑞医药:10月30日回购公司股份55880股 - Reportify